FDA approves Pfizer’s RSV shot for older adults, teeing up a competitive $17B vaccine market

FDA approves Pfizer’s RSV shot for older adults, teeing up a competitive $17B vaccine market

Upworthy

Published

The FDA approved Pfizer’s RSV vaccine called Abrysvo for older adults on Wednesday, placing another Big Pharma onto the commercial stage ahead of the next RSV season. Pfizer’s approval comes weeks after GSK won approval for its rival shot, Arexvy. Those two vaccines are both approved for use in…

#fda #pfizer #rsv #abrysvo #gsk #arexvy #cdc #jefferies

Full Article